TrialBreast cancer research : BCR2006

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].

Trevor Powles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.